A population-based analysis of the impact of 1 vs. 2 doses of mitomycin on patterns of failure of anal cancer patients treated with concurrent chemoradiotherapy.
Joseph K, Al Habsi Z, Abraham A, Elangovan A, Ghosh S, Pham T, Shreekumar D, Ramji Z, Paulson K, Tankel K, Usmani N, Severin D, Schiller D, Wong C, Mulder K, Karachiwala H, Doll C, King K, Nijjar T.
Joseph K, et al. Among authors: nijjar t.
Radiother Oncol. 2024 Jul;196:110219. doi: 10.1016/j.radonc.2024.110219. Epub 2024 Mar 12.
Radiother Oncol. 2024.
PMID: 38479443